Chongqing Lummy Pharmaceutical Co., Ltd. (300006.SZ)
CNY 5.25
(-2.42%)
CNY 5.25
(-2.42%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 170.99 Million CNY | -15.52% |
| 2022 | 202.4 Million CNY | 28.28% |
| 2021 | 157.77 Million CNY | -46.82% |
| 2020 | 296.65 Million CNY | -6.33% |
| 2019 | 316.71 Million CNY | 1.59% |
| 2018 | 311.74 Million CNY | -9.9% |
| 2017 | 346 Million CNY | 3.7% |
| 2016 | 333.65 Million CNY | -3.72% |
| 2015 | 346.53 Million CNY | 25.93% |
| 2014 | 275.18 Million CNY | 62.24% |
| 2013 | 169.61 Million CNY | 13.85% |
| 2012 | 148.97 Million CNY | 9.16% |
| 2011 | 136.47 Million CNY | 16.85% |
| 2010 | 116.79 Million CNY | 76.05% |
| 2009 | 66.34 Million CNY | 2.56% |
| 2008 | 64.68 Million CNY | 64.3% |
| 2007 | 39.37 Million CNY | 160.62% |
| 2006 | 15.1 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 179.64 Million CNY | 5.06% |
| 2024 Q2 | 166.4 Million CNY | -7.37% |
| 2024 Q3 | 192.67 Million CNY | 15.79% |
| 2023 Q1 | 192.76 Million CNY | -4.76% |
| 2023 FY | 170.99 Million CNY | -15.52% |
| 2023 Q4 | 170.99 Million CNY | -1.64% |
| 2023 Q3 | 173.84 Million CNY | -11.19% |
| 2023 Q2 | 195.75 Million CNY | 1.55% |
| 2022 FY | 202.4 Million CNY | 28.28% |
| 2022 Q1 | 172.39 Million CNY | 9.27% |
| 2022 Q4 | 202.4 Million CNY | 17.94% |
| 2022 Q2 | 193.18 Million CNY | 12.06% |
| 2022 Q3 | 171.6 Million CNY | -11.17% |
| 2021 Q3 | 221.36 Million CNY | -5.24% |
| 2021 Q4 | 157.77 Million CNY | -28.73% |
| 2021 Q2 | 233.61 Million CNY | 2.03% |
| 2021 FY | 157.77 Million CNY | -46.82% |
| 2021 Q1 | 228.96 Million CNY | -22.82% |
| 2020 Q1 | 372.82 Million CNY | 17.72% |
| 2020 FY | 296.65 Million CNY | -6.33% |
| 2020 Q2 | 368.32 Million CNY | -1.21% |
| 2020 Q3 | 322.93 Million CNY | -12.33% |
| 2020 Q4 | 296.65 Million CNY | -8.14% |
| 2019 Q1 | 302.45 Million CNY | -2.98% |
| 2019 FY | 316.71 Million CNY | 1.59% |
| 2019 Q2 | 267 Million CNY | -11.72% |
| 2019 Q4 | 316.71 Million CNY | 19.8% |
| 2019 Q3 | 264.37 Million CNY | -0.99% |
| 2018 Q4 | 311.74 Million CNY | -21.96% |
| 2018 FY | 311.74 Million CNY | -9.9% |
| 2018 Q3 | 399.44 Million CNY | -1.14% |
| 2018 Q2 | 404.03 Million CNY | 16.86% |
| 2018 Q1 | 345.74 Million CNY | -0.07% |
| 2017 Q2 | 377.7 Million CNY | 11.89% |
| 2017 Q1 | 337.56 Million CNY | 1.17% |
| 2017 Q3 | 374.96 Million CNY | -0.73% |
| 2017 Q4 | 346 Million CNY | -7.72% |
| 2017 FY | 346 Million CNY | 3.7% |
| 2016 Q4 | 333.65 Million CNY | -12.44% |
| 2016 Q3 | 381.05 Million CNY | 6.71% |
| 2016 Q2 | 357.09 Million CNY | 7.7% |
| 2016 Q1 | 331.55 Million CNY | -4.32% |
| 2016 FY | 333.65 Million CNY | -3.72% |
| 2015 Q2 | 431.99 Million CNY | 13.21% |
| 2015 Q4 | 346.53 Million CNY | -10.53% |
| 2015 FY | 346.53 Million CNY | 25.93% |
| 2015 Q3 | 387.32 Million CNY | -10.34% |
| 2015 Q1 | 381.6 Million CNY | 38.67% |
| 2014 Q2 | 224.13 Million CNY | 28.87% |
| 2014 FY | 275.18 Million CNY | 62.24% |
| 2014 Q1 | 173.91 Million CNY | 2.54% |
| 2014 Q3 | 277.5 Million CNY | 23.81% |
| 2014 Q4 | 275.18 Million CNY | -0.84% |
| 2013 Q1 | 154.37 Million CNY | 3.62% |
| 2013 Q2 | 178.67 Million CNY | 15.75% |
| 2013 FY | 169.61 Million CNY | 13.85% |
| 2013 Q3 | 188.81 Million CNY | 5.67% |
| 2013 Q4 | 169.61 Million CNY | -10.17% |
| 2012 Q3 | 133.95 Million CNY | 14.15% |
| 2012 Q4 | 148.97 Million CNY | 11.22% |
| 2012 Q2 | 117.34 Million CNY | -15.45% |
| 2012 FY | 148.97 Million CNY | 9.16% |
| 2012 Q1 | 138.79 Million CNY | 1.7% |
| 2011 Q2 | 115.09 Million CNY | 9.55% |
| 2011 FY | 136.47 Million CNY | 16.85% |
| 2011 Q4 | 136.47 Million CNY | 10.51% |
| 2011 Q3 | 123.49 Million CNY | 7.3% |
| 2011 Q1 | 105.06 Million CNY | -10.04% |
| 2010 Q1 | 72.77 Million CNY | 9.7% |
| 2010 Q4 | 116.79 Million CNY | 43.75% |
| 2010 FY | 116.79 Million CNY | 76.05% |
| 2010 Q3 | 81.25 Million CNY | 8.11% |
| 2010 Q2 | 75.15 Million CNY | 3.27% |
| 2009 Q2 | 59.68 Million CNY | 0.0% |
| 2009 FY | 66.34 Million CNY | 2.56% |
| 2009 Q4 | 66.34 Million CNY | 10.07% |
| 2009 Q3 | 60.27 Million CNY | 0.98% |
| 2008 Q4 | 64.68 Million CNY | 0.0% |
| 2008 FY | 64.68 Million CNY | 64.3% |
| 2007 FY | 39.37 Million CNY | 160.62% |
| 2006 FY | 15.1 Million CNY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 3.57 Billion CNY | 95.211% |
| Zhejiang Zhenyuan Share Co., Ltd. | 679.41 Million CNY | 74.832% |
| Hunan Jingfeng Pharmaceutical Co.,Ltd. | 64.57 Million CNY | -164.793% |
| Hubei Guangji Pharmaceutical Co., Ltd. | 298.99 Million CNY | 42.809% |
| Yifan Pharmaceutical Co., Ltd. | 928.6 Million CNY | 81.586% |
| Guangdong Jiaying Pharmaceutical Co., Ltd | 84.6 Million CNY | -102.124% |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 3.83 Billion CNY | 95.547% |
| Boai NKY Medical Holdings Ltd. | 309.8 Million CNY | 44.805% |
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | 59.03 Million CNY | -189.641% |